O	0	9	Autocrine	Autocrine	JJ	B-NP
O	10	20	angiogenic	angiogenic	JJ	I-NP
B-Multi-tissue_structure	21	29	vascular	vascular	JJ	I-NP
O	30	40	prosthesis	prosthesis	NN	I-NP
O	41	45	with	with	IN	B-PP
B-Multi-tissue_structure	46	50	bone	bone	NN	B-NP
I-Multi-tissue_structure	51	57	marrow	marrow	NN	I-NP
O	58	73	transplantation	transplantation	NN	I-NP
O	73	74	.	.	.	O

O	75	84	Synthetic	Synthetic	JJ	B-NP
B-Multi-tissue_structure	85	93	vascular	vascular	JJ	I-NP
O	94	104	prostheses	prosthesis	NNS	I-NP
O	105	108	are	be	VBP	B-VP
O	109	116	foreign	foreign	JJ	B-NP
O	117	123	bodies	body	NNS	I-NP
O	123	124	,	,	,	O
O	125	127	so	so	IN	B-SBAR
O	128	132	that	that	IN	I-SBAR
B-Organism_substance	133	138	blood	blood	NN	B-NP
O	139	150	coagulation	coagulation	NN	I-NP
O	151	154	can	can	MD	B-VP
O	155	160	occur	occur	VB	I-VP
O	161	163	on	on	IN	B-PP
O	164	169	their	their	PRP$	B-NP
B-Multi-tissue_structure	170	177	luminal	luminal	JJ	I-NP
I-Multi-tissue_structure	178	186	surfaces	surface	NNS	I-NP
O	186	187	,	,	,	O
O	188	195	causing	cause	VBG	B-VP
B-Multi-tissue_structure	196	201	graft	graft	NN	B-NP
O	202	211	occlusion	occlusion	NN	I-NP
O	212	216	very	very	RB	B-ADVP
O	217	227	frequently	frequently	RB	I-ADVP
O	228	230	in	in	IN	B-PP
O	231	241	prostheses	prosthesis	NNS	B-NP
O	242	244	of	of	IN	B-PP
O	245	250	small	small	JJ	B-NP
O	251	259	diameter	diameter	NN	I-NP
O	259	260	.	.	.	O

O	261	262	A	A	DT	B-NP
B-Multi-tissue_structure	263	271	vascular	vascular	JJ	I-NP
O	272	282	prosthesis	prosthesis	NN	I-NP
O	283	288	needs	need	VBZ	B-VP
O	289	301	angiogenesis	angiogenesis	NN	B-NP
O	302	305	for	for	IN	B-PP
O	306	324	endothelialization	endothelialization	NN	B-NP
O	325	327	of	of	IN	B-PP
O	328	331	the	the	DT	B-NP
B-Multi-tissue_structure	332	339	luminal	luminal	JJ	I-NP
I-Multi-tissue_structure	340	347	surface	surface	NN	I-NP
O	347	348	,	,	,	O
O	349	351	as	as	IN	B-SBAR
B-Cell	352	363	endothelial	endothelial	JJ	B-NP
I-Cell	364	369	cells	cell	NNS	I-NP
O	370	374	have	have	VBP	B-VP
O	375	382	natural	natural	JJ	B-NP
O	383	386	and	and	CC	I-NP
O	387	396	permanent	permanent	JJ	I-NP
O	397	413	antithrombogenic	antithrombogenic	JJ	I-NP
O	414	424	properties	property	NNS	I-NP
O	424	425	.	.	.	O

O	426	428	To	To	TO	B-VP
O	429	435	induce	induce	VB	I-VP
B-Tissue	436	445	capillary	capillary	JJ	B-NP
O	446	452	growth	growth	NN	I-NP
O	453	457	into	into	IN	B-PP
O	458	461	the	the	DT	B-NP
B-Multi-tissue_structure	462	467	graft	graft	NN	I-NP
O	467	468	,	,	,	O
O	469	471	we	we	PRP	B-NP
O	472	481	developed	develop	VBD	B-VP
O	482	483	a	a	DT	B-NP
O	484	490	method	method	NN	I-NP
O	491	493	of	of	IN	B-PP
O	494	507	transplanting	transplant	VBG	B-VP
B-Cell	508	512	bone	bone	NN	B-NP
I-Cell	513	519	marrow	marrow	NN	I-NP
I-Cell	520	525	cells	cell	NNS	I-NP
O	525	526	,	,	,	O
O	527	532	which	which	WDT	B-NP
O	533	536	are	be	VBP	B-VP
O	537	546	primitive	primitive	JJ	B-ADJP
O	546	547	,	,	,	O
O	548	554	strong	strong	JJ	B-ADJP
O	555	561	enough	enough	RB	I-ADJP
O	562	564	to	to	TO	B-VP
O	565	572	survive	survive	VB	I-VP
O	572	573	,	,	,	O
O	574	577	and	and	CC	O
O	578	584	create	create	VB	B-VP
B-Cell	585	590	blood	blood	NN	B-NP
I-Cell	591	596	cells	cell	NNS	I-NP
O	596	597	,	,	,	O
O	598	607	resulting	result	VBG	B-VP
O	608	610	in	in	IN	B-PP
O	611	614	the	the	DT	B-NP
O	615	625	inducement	inducement	NN	I-NP
O	626	628	of	of	IN	B-PP
B-Tissue	629	638	capillary	capillary	JJ	B-NP
O	639	645	growth	growth	NN	I-NP
O	645	646	.	.	.	O

O	647	649	In	In	IN	B-PP
O	650	652	an	an	DT	B-NP
O	653	659	animal	animal	NN	I-NP
O	660	670	experiment	experiment	NN	I-NP
O	670	671	,	,	,	O
B-Cell	672	678	marrow	marrow	NN	B-NP
I-Cell	679	684	cells	cell	NNS	I-NP
O	685	689	were	be	VBD	B-VP
O	690	701	infiltrated	infiltrate	VBN	I-VP
O	702	706	into	into	IN	B-PP
O	707	710	the	the	DT	B-NP
O	711	716	walls	wall	NNS	I-NP
O	717	719	of	of	IN	B-PP
O	720	724	long	long	JJ	B-NP
O	724	725	-	-	HYPH	I-NP
O	725	731	fibril	fibril	NN	I-NP
O	732	740	expanded	expand	VBN	I-NP
O	741	764	polytetrafluoroethylene	polytetrafluoroethylene	NN	I-NP
O	765	766	(	(	(	O
O	766	771	ePTFE	ePTFE	NN	B-NP
O	771	772	)	)	)	O
B-Multi-tissue_structure	773	781	vascular	vascular	JJ	B-NP
I-Multi-tissue_structure	782	788	grafts	graft	NNS	I-NP
O	788	789	.	.	.	O

O	790	793	The	The	DT	B-NP
B-Multi-tissue_structure	794	800	grafts	graft	NNS	I-NP
O	801	805	were	be	VBD	B-VP
O	806	815	implanted	implant	VBN	I-VP
O	816	818	in	in	IN	B-PP
O	819	822	the	the	DT	B-NP
B-Multi-tissue_structure	823	832	abdominal	abdominal	JJ	I-NP
I-Multi-tissue_structure	833	839	aortic	aortic	JJ	I-NP
O	840	848	position	position	NN	I-NP
O	849	851	of	of	IN	B-PP
O	852	854	24	24	CD	B-NP
O	855	859	dogs	dog	NNS	I-NP
O	860	872	autologously	autologously	RB	B-ADVP
O	872	873	.	.	.	O

B-Cell	874	880	Marrow	Marrow	NN	B-NP
I-Cell	881	886	cells	cell	NNS	I-NP
O	887	895	survived	survive	VBD	B-VP
O	896	899	and	and	CC	O
O	900	909	continued	continue	VBD	B-NP
O	910	919	exogenous	exogenous	JJ	I-NP
O	920	931	hemopoiesis	hemopoiesis	NN	I-NP
O	932	935	for	for	IN	B-PP
O	936	938	up	up	RB	B-NP
O	939	941	to	to	TO	I-NP
O	942	945	six	six	CD	I-NP
O	946	952	months	month	NNS	I-NP
O	953	956	and	and	CC	O
O	957	961	were	be	VBD	B-VP
O	962	983	immunohistochemically	immunohistochemically	RB	B-ADJP
O	984	992	reactive	reactive	JJ	I-ADJP
O	993	995	to	to	TO	B-PP
O	996	1001	basic	basic	JJ	B-NP
O	1002	1012	fibroblast	fibroblast	NN	I-NP
O	1013	1019	growth	growth	NN	I-NP
O	1020	1026	factor	factor	NN	I-NP
O	1027	1028	(	(	(	O
O	1028	1032	bFGF	bFGF	NN	B-NP
O	1032	1033	)	)	)	O
O	1033	1034	.	.	.	O

O	1035	1038	All	All	PDT	B-NP
O	1039	1042	the	the	DT	I-NP
B-Multi-tissue_structure	1043	1049	grafts	graft	NNS	I-NP
O	1050	1055	older	old	JJR	B-ADJP
O	1056	1060	than	than	IN	B-PP
O	1061	1066	three	three	CD	B-NP
O	1067	1072	weeks	week	NNS	I-NP
O	1073	1076	had	have	VBD	B-VP
O	1077	1085	complete	complete	JJ	B-NP
O	1086	1104	endothelialization	endothelialization	NN	I-NP
O	1105	1108	and	and	CC	O
O	1109	1119	maintained	maintain	VBD	B-VP
O	1120	1125	their	their	PRP$	B-NP
O	1126	1133	patency	patency	NN	I-NP
O	1133	1134	.	.	.	O

O	1135	1141	Twenty	Twenty	CD	B-NP
B-Multi-tissue_structure	1142	1148	grafts	graft	NNS	I-NP
O	1149	1156	without	without	IN	B-PP
B-Multi-tissue_structure	1157	1161	bone	bone	NN	B-NP
I-Multi-tissue_structure	1162	1168	marrow	marrow	NN	I-NP
O	1169	1173	were	be	VBD	B-VP
O	1174	1183	implanted	implant	VBN	I-VP
O	1184	1186	as	as	IN	B-PP
O	1187	1195	controls	control	NNS	B-NP
O	1195	1196	.	.	.	O

O	1197	1215	Endothelialization	Endothelialization	NN	B-NP
O	1216	1219	was	be	VBD	B-VP
O	1220	1227	present	present	JJ	B-ADJP
O	1228	1230	at	at	IN	B-PP
B-Tissue	1231	1242	anastomotic	anastomotic	JJ	B-NP
I-Tissue	1243	1248	sites	site	NNS	I-NP
O	1248	1249	,	,	,	O
O	1250	1253	but	but	CC	O
O	1254	1259	other	other	JJ	B-NP
O	1260	1265	areas	area	NNS	I-NP
O	1266	1270	were	be	VBD	B-VP
O	1271	1278	covered	cover	VBN	I-VP
O	1279	1283	with	with	IN	B-PP
O	1284	1289	fresh	fresh	JJ	B-NP
B-Pathological_formation	1290	1297	thrombi	thrombi	NN	I-NP
O	1297	1298	.	.	.	O

O	1299	1303	Four	Four	CD	B-NP
O	1304	1307	out	out	IN	I-NP
O	1308	1310	of	of	IN	B-PP
O	1311	1316	seven	seven	CD	B-NP
O	1317	1324	control	control	NN	I-NP
B-Multi-tissue_structure	1325	1331	grafts	graft	NNS	I-NP
O	1332	1336	were	be	VBD	B-VP
O	1337	1343	patent	patent	NN	B-NP
O	1344	1348	with	with	IN	B-PP
B-Cell	1349	1360	endothelial	endothelial	JJ	B-NP
I-Cell	1361	1365	cell	cell	NN	I-NP
O	1366	1372	lining	lining	NN	I-NP
O	1373	1375	at	at	IN	B-PP
O	1376	1379	six	six	CD	B-NP
O	1380	1386	months	month	NNS	I-NP
O	1386	1387	,	,	,	O
O	1388	1391	but	but	CC	O
O	1392	1397	three	three	CD	B-NP
O	1398	1402	were	be	VBD	B-VP
O	1403	1411	occluded	occlude	VBN	I-VP
O	1412	1415	and	and	CC	O
O	1416	1419	one	one	CD	B-NP
O	1420	1422	of	of	IN	B-PP
O	1423	1426	the	the	DT	B-NP
O	1427	1431	four	four	CD	I-NP
B-Multi-tissue_structure	1432	1438	grafts	graft	NNS	I-NP
O	1439	1442	was	be	VBD	B-VP
O	1443	1448	still	still	RB	I-VP
O	1449	1456	covered	cover	VBN	I-VP
O	1457	1461	with	with	IN	B-PP
O	1462	1463	a	a	DT	B-NP
B-Pathological_formation	1464	1472	thrombus	thrombus	NN	I-NP
I-Pathological_formation	1473	1478	layer	layer	NN	I-NP
O	1478	1479	.	.	.	O

B-Multi-tissue_structure	1480	1484	Bone	Bone	NN	B-NP
I-Multi-tissue_structure	1485	1491	marrow	marrow	NN	I-NP
O	1492	1496	with	with	IN	B-PP
O	1497	1500	its	its	PRP$	B-NP
O	1501	1507	unique	unique	JJ	I-NP
O	1508	1514	native	native	JJ	I-NP
O	1515	1525	properties	property	NNS	I-NP
O	1526	1534	produced	produce	VBD	B-VP
O	1535	1544	autocrine	autocrine	JJ	B-NP
O	1545	1558	angiogenicity	angiogenicity	NN	I-NP
O	1559	1561	in	in	IN	B-PP
O	1562	1565	the	the	DT	B-NP
B-Multi-tissue_structure	1566	1571	graft	graft	NN	I-NP
O	1571	1572	.	.	.	O

